Avsnitt
-
We discuss several of the important data coming out the American Heart Association 2020 meeting. Thanks for listening. Please like, subscribe and give us a rating.
-
We have a multispecialty panel discussion on the cardiorenal benefits of newer antidiabetic agents with Drs Rangaswami, Vaduganathan, Tuttle and Bhalla. Thanks for listening. Please like, subscribe and give us a rating.
-
Saknas det avsnitt?
-
We discuss several of the important data coming out the European Society of Cardiology 2020 meeting. Thanks for listening. Please like, subscribe and give us a rating.
-
We discuss cardiogenic shock and decision making in the case of a young female presenting to the ER. We have a panel of cardiologists guide the discussion. Drs Rene Alvarez, Daniel Sims and Alec Vishnevski discuss the case presented by cardiology fellow Rachna Kataria, MD. Thanks for listening. Please like, subscribe and give us a rating.
-
We discuss the various aspects of cardiogenic shock including definition, heterogeneity, classification and management with an internationally renowned expert in the field Dr Navin Kapur. Dr Kapur is the Director of the Acute Mechanical Circulatory Support Program at Tufts University School of Medicine, Boston, MA. Listen, like, subscribe, and give us a high rating.
-
We discuss several aspects of cardio-oncology including screening protocols, specific chemotherapy related cardiotoxicities and management of cardiovascular disease among cancer patients and cancer survivors. Dr Sherry-Ann Brown is the director of Cardio-Oncology at the Medical College of Wisconsin, Milwaukee, WI. Listen, like, subscribe, and give us a high rating.
-
We discuss several aspects of cardiac arrhythmias and their management among cancer patients and cancer survivors with Drs Fradley and Guha. Dr Fradley is an electrophysiologist and Dr Guha is a non-invasive cardiologist, both with tremendous expertise in cardio-oncology. Dr Fradley is the Medical Director of Cardio-Oncology at University of Pennsylvania, Philadelphia, PA. Listen, like, subscribe, and give us a high rating.
-
We discuss some radiation physics, role for ionizing radiation in treating cancer & related cardiac damage with Dr Brett Lewis MD PhD. Dr. Lewis has interest & expertise in treating several thoracic malignancies & practices at Hackensack Meridian Health, NJ. Listen, like, subscribe, and give us a high rating.
-
We discuss several classes of cancer therapies including chemotherapy, immunotherapy, CAR T-Cell therapies and related cardiovascular toxicity from the perspective of a board certified oncologist Dr Kaushal Parikh, MD. Dr Parikh specializes in thoracic oncology and practices at Hackensack Meridian Health, NJ. Listen, Like, Subscribe, and give us a high rating!
-
We review and discuss a lot of exciting data including late-breaking trials from the American College of Cardiology Scientific Sessions in March, 2020. Listen, Like, Subscribe, and give us a high rating!
-
We review the inpatient management in HFrEF, role of GDMT initiation & HF exacerbating drugs. We end the episode with a discussion on HFpEF & device therapies with Professor Carolyn Lam, a Senior Consultant of the National Heart Centre, Singapore and Professor of Duke-NUS Cardiovascular Academic Clinical Program. Listen, Like, Subscribe, and give us a rating!
-
We discuss Coronavirus Disease 2019 and cardiovascular involvement. Dr Jennifer Haythe, a Heart Failure cardiologist from Columbia University Medical Center talks about the cardiovascular sequelae associated with COVID-19 and related management. We end with HCW protection, appropriate PPE, new data of HCQ and investigational therapies. Listen, Like, Subscribe, and give us a rating!
-
We discuss Coronavirus Disease 2019 in the USA. Dr Udit Chaddha, a Pulmonary Disease & Critical Care specialist from the Icahn School of Medicine - Mount Sinai Hospital in New York talks about the virus, disease identification, healthcare worker protection and management of related acute respiratory illness. Listen, Like, Subscribe, and give us a rating!
-
We discuss transthyretin (aTTR) cardiac amyloidosis, symptoms, appropriate diagnostic testing and different treatment options available. Dr. Mathew Maurer from NewYork-Presbyterian Hospital/Columbia University shares his expertise with us. Listen, Like, Subscribe, and give us a rating!
-
Management of light chain or AL amyloidosis has changed with major advances in recent years. Dr. Ronald Witteles is a Stanford Cardiologist with particular expertise in the treatment of cardiac amyloidosis and shares his expertise with us. He serves as Co-Director of the Stanford Amyloid Center, one of the world's leading amyloid centers. Listen, Like, Subscribe, and give us a rating!
-
Sudden cardiac death in heart failure has changed as therapies have evolved. We discuss arrhythmic and non arrhythmic sudden death in heart failure, and how we can lower its incidence. Dr Nasrien Ibrahim MD from Massachusetts General Hospital affiliated with Harvard Medical School shares her expertise. Listen, Like, Subscribe, and give us a rating!
-
Diabetes management is evolving and we discuss the role of cardiologists in improving cardio-metabolic care. Dr Muthiah Vaduganathan MD MPH from Brigham and Women's Hospital & Harvard Medical School shares his expertise on the evidence for newer drugs and how cardiologists can get engaged in diabetes management. This is episode three of four in our Diabeto-Cardiology series. Listen, Like, Subscribe, Tweet and don't forget to give us a Rating!!
-
Big trials presented at AHA 2019!! We have two interviews and we discuss ISCHEMIA, ISCHEMIA CKD, COLCOT, ORION-10, BETonMACE, AVR in asymptomatic very severe AS, GALILEO, DAPA-HF, and the Apple Heart study. Listen, Like, Subscribe and don't forget to give us a Rating!!
-
Diabetes management is changing rapidly, and with that we have newer management strategies with cardiovascular benefit. Dr Ritika Puri shares an endocrinologist's perspective on where diabetes stands today, and shares interesting insights into how to approach cardiovascular disease in diabetes management. This is episode two of four in our Diabeto-Cardiology series. Listen, Like, Subscribe and don't forget to give us a Rating!!
-
Ilya Danelich PharmD (Board Certified Cardiac Pharmacist) walks us through the mechanism of action and pearls for different classes of diabetic drugs including the NEWER drugs. We also describe how to prescribe the newer SGLT2 inhibitors and review mechanisms for adverse effects and cardiovascular/renal benefits. This is episode one of four in our Diabeto-Cardiology series. Listen, Like, Subscribe and don't forget to give us a Rating!!
- Visa fler
